Can the road to profitable medical device technologies be smoother and more predictable? The short answer is yes.

Despite a multitude of regulations, companies can effectively ‘fast track’ their efforts by avoiding pitfalls. Having to re-conduct a single trial or re-submit can be the cost and time expense that breaks an emerging company. A number of functions can be effectively leveraged in the device development process to increase chances of success:

• Human factors & usability
• Verification & validation
• Manufacturing preparation

Early engagement and integration of these activities has a definite payoff. New technologies can be brought to market within a risk threshold, yet without sacrificing safety or effectiveness.

Our expert panel will speak about medical device development activities that can actually be predictable and controllable. We will discuss cases of med device companies that followed these routes, their outcomes in getting to market, and how this can apply to your product.

These best practices will keep your company on track and provide a means to hitting key milestones, obtaining clearance, and/or getting acquired.

RSVP

Panelists include:

Shannon Clark, CEO at UserWise
Howard Edelman, Chairman Medical Devices & Digital Health Screening Committee, Life Science Angels
Noreen King, President and CEO at Evolve Manufacturing